in Kooperation mit der Deutschen Vereinigung zur Bekämpfung der Viruskrankheiten e.V.

Sie sind hier


Postdoc/PhD-student positions available:

Development of broadly acting antivirals targeting conserved host cell mechanisms and viral structures.

PI: Prof. Michael Schindler, Institute for Medical Virology, Tübingen, Germany

Synopsis: The SARS-CoV-2 pandemic and its devastating impact on mankind, considering not only the viral death toll but also the socioeconomic consequences of the pandemic, emphasizes the importance of conducting research in antiviral therapy. There is a constant threat of emerging and re-emerging viral pathogens that ultimately might have the potential to cause pandemics in a manner comparable to SARS-CoV-2. Hence, even though there is hope for an effective vaccine against SARS-CoV-2, the development of broadly acting antivirals is a top priority to be prepared for potential novel viral pathogens. The Research Section Molecular Virology at the University Hospital Tübingen has several developmental projects aiming to establish novel broadly acting antivirals. Our purpose is to identify and target either conserved viral structural elements or host cell pathways that are exploited by viruses for replication.

See the full job description